Fingerprint
Dive into the research topics of 'Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically